P01.01 - Methylproteome and Phosphoproteome Crosstalk in the Maintenance and Differentiation of Glioma Cancer Stem Cells (View Slides)

Byron Baron

P01.02 - Cellular Protein Perturbations Identify Toxicity Pathways Associated with ZnO Nanoform Exposures (View Slides)

Premkumari Kumarathasan

P01.03 - Future Perspectives and Strategies for Data-Independent Acquisition on Orbitrap MS Instruments (View Slides)

Yansheng Liu

P01.04 - Progress Identifying and Analyzing the Human Proteome: 2021 Metrics from the HUPO Human Proteome Project (View Slides)

Gilbert S. Omenn

P01.05 - A TMTpro 18plex Proteomics Standard for Assessing Protein Measurement Accuracy and Precision (View Slides)

Bhavin Patel

P02.01 - Evaluation of Long Nanoflow Columns with Core-Shell Based Chromatographic Phases in Data Dependent Acquisition Workflows (View Slides)

Alexandra Antonoplis

P02.02 - Maximizing sensitivity gains with ultra-low nano-flow LCMS analysis enabled by nextgeneration low-flow UHPLC system (View Slides)

Runsheng Zheng

P02.04 - Real-Time Search Assisted Acquisition on a Tribrid Mass Spectrometer Improves Coverage of Multiplexed Single-Cell Proteomics (View Slides)

Benjamin Furtwängler

P02.05 - A Highly Efficient and Automated Workflow for Label-Free and Multiplexed Single Cell Proteomics (View Slides)

David Hartlmayr

P02.06 - Digital Microfluidics for Proteomics Analysis of Few or Single Mammalian Cells (View Slides)

Jan Leipert

P02.07 - Streamlined Single-Cell Proteomics by the All-in-One Chip and Data-Independent Acquisition Mass Spectrometry (View Slides)

Hsiung-Lin Tu

P02.08 - Comparison of Epithelial and Stromal Proteomes from Colorectal Adenoma to Carcinoma (View Slides)

Keqiang Yan

P03.01 - Defining Mechanisms Underlying Virus Regulation of Mitochondrial Bioenergetics During Infection (View Slides)

Cora Betsinger

P03.02 - Cell-Surface Proteomics: Novel Methodology for Identifying Cell-Surface Proteins of Toxic Dinoflagellates (View Slides)

Kenrick Kai-yuen Chan

P03.03 - The Human Fallopian Tube Proteome (View Slides)

Andreas Digre

P03.04 - Identification of Cell Type-Specific Endometrial Markers through Integration of Single-Cell Transcriptomics and Spatial Proteomics (View Slides)

Åsa Edvinsson

P03.06 - System Wide Profiling of Protein Interaction Dynamics Links Host Innate Immunity and DNA Damage Responses (View Slides)

Joshua Justice

P03.07 - Spatial Proteomics Analysis of Ovaries from Women in Reproductive Age (View Slides)

Loren Méar

P03.08 - Differential Regulation of Promyelocytic Leukemia-Nuclear Body (PML-NB) Proteins during Oncogene Induced Senescence (View Slides)

Rodrigo Mohallem Ferreira

P03.09 - Combining SDS with Subcritical for Continuous Flowthrough Extraction of Proteins from Food Samples. (View Slides)

Hammam Said

P03.10 - Impacts of Intracellular-Advanced Glycation End Products in Pancreatic Ductal Epithelial Cells (View Slides)

Lakmini Senavirathna

P03.11 - Streamlined Use of Protein Structures and Virtual Reality to Analyse Variants (View Slides)

Neblina Sikta

P04.01 - Ghost Proteome Revealed Involved in Functional Regulator of Glioma Using Crosslink Mass Spectrometry (View Slides)

Tristan Cardon

P04.02 - Proteomic Investigation of Stress-Induced Neurological Changes in Brain Regions of an Alzheimer’s Disease Transgenic Mouse Model (View Slides)

Amalie Clement

P04.03 - Deep Proteomic Profiling of Alzheimer's Disease CSF for Unbiased Biomarker Discovery and Subject Stratification (View Slides)

P04.04 - Dynamics of Huntingtin Protein Interactions in the Striatum Identifies Candidate Modifiers of Huntington’s Disease (View Slides)

Todd Greco

P04.05 - Brain Glycoproteomic Network Alterations in Alzheimer’s Disease (View Slides)

Lian Li

P04.06 - Omics Insights into Gender Differences in Alzheimer Disease Subjects (View Slides)

Elisa Maffioli

P04.07 - Identification of Proteins Altered in Alzheimer’s Disease by Mass Spectrometry That Could Be Key for the Understanding of the Disease (View Slides)

Ana Montero Calle

P04.08 - Proteomic Analysis of Three Brain Regions Isolated from Patients with Mesial Temporal Lobe Epilepsy Reveals Molecular Alterations beyond the Hippocampus (View Slides)

Amanda Morato Do Canto

P04.09 - Differential Proteomic Analysis of Astrocytes and Astrocytes-Derived Extracellular Vesicles from Control and Rai Knockout Mice: Insights into Neuroprotective Mechanisms (View Slides)

Enxhi Shaba

P04.10 - Assessment of IsoAsp7 Amyloid-beta Peptides as a Perspective Diagnostic Target of AD Progression by Proteomic MS Based Approaches (View Slides)

Polina Strelnikova

P04.11 - Proteomic Profiling Provides New Insights into the Role of Neuromelanin Granules in Neurodegenerative Processes (View Slides)

P04.12 - Mitochondrial, Cell Cycle Control and Neuritogenesis Alterations in an IPSC-Based Neurodevelopmental Model for Schizophrenia (View Slides)

Giuliana Zuccoli

P05.02 - A Survey of the Cancer Conformational Landscape Establishes Novel Anti-Cancer Drug Targets (View Slides)

Tom Casimir Bamberger

P05.03 - Proteomics and Large-Scale, Comparative Cross-Linking Mass Spectrometry Reveal Novel Roles for Ribosome Histidine Methylation (View Slides)

Tara Bartolec

P05.04 - Assessing Therapeutic Diet-Induced Succinylome Remodeling in Injured Kidney and Liver using Library-Free Data-Independent Acquisition (View Slides)

Joanna Bons

P05.05 - Interactome Analyses and HDX-MS Reveal Profound Proteasome Structural and Functional Rearrangements throughout Mammalian Spermatogenesis (View Slides)

Dušan Živković

P05.06 - A Structural Analysis of Heated Ovalbumin by Crosslink Proteomics (View Slides)

Mehdi Cherkaoui

P05.07 - N-Glycoproteome from a Cancer Cell Line and Its Non-tumorigenic Cell Line Combining Fbs1-GYR N-Glycopeptide Enrichment and Trapped-Ion-Mobility-Quadrupole-Time-of-Flight (View Slides)

Michael Krawitzky

P05.08 - Proteomics of A-to-I Rna Editing in Mouse and Human (View Slides)

Ksenia Kuznetsova

P05.09 - Mapping the Functional Proteome Landscape of Escherichia Coli with Thermal Proteome Profiling (View Slides)

André Mateus

P05.11 - HaDeX 2.0: Web-Server and R Package for the Hydrogen-Deuterium Exchange Mass Spectrometry Experiments Data (View Slides)

P05.12 - Prolonged Exposure to Traffic-Related Particulate Matter and Gaseous Pollutants Implicate Distinct Molecular Mechanisms of Lung Injury in Rats (View Slides)

Denise Utami Putri

P06.01 - Dysregulation of Plasma Proteome Induced by SARS-CoV-2 and MERS-CoV Infections Reveal Biomarkers for COVID-19 Patients Disease Outcomes (View Slides)

Ayodele Alaiya

P06.02 - Proteomic Analysis of the Upper Respiratory Proteins from COVID 19 Patients: A Gel Based Approach. (View Slides)

Stefania Angelucci

P06.04 - Targeted MS Based Multi-Omic Analysis of Blood Plasma from Hospitalized COVID-19 Patients Reveals Predictive Molecular Signatures of Survival (View Slides)

Vincent Richard

P06.05 - The secretome signature for identifying biomarkers (View Slides)

Sandrine Bourgoin

P06.06 - Data-Independent Acquisition Mass Spectrometry (DIA-MS) Analysis Identifies a Neutrophil Proteomic Signature in COVID-19 Infection (View Slides)

Alejandro J. Brenes

P06.07 - Quantitative Proteome and Phosphoproteome Analysis of A549-ACE2 Cells after Infection with Sars-COV2 – A Pilot Study (View Slides)

Fernando Corrales

P06.08 - Glycopeptide Mapping for Comparison of CHO and HEK Cell Derived SARS-Cov-2 Spike Trimeric Protein Antigen (View Slides)

Caroline Evans

P06.09 - Sex differences in Autoantibodies Response to SARS-CoV-2 Infection (View Slides)

Justyna Fert-Bober

P06.10 - SARS-CoV-2 Infection Triggers Auto-Immune Response in ARDS (View Slides)

Manuel Fuentes

P06.11 - Utilisation of Cyclic Ion Mobility with Multiple Pass Acquisition for the Analysis of Glycopeptides and Glycoforms Associated with SARS-CoV-2 (View Slides)

Lee Gethings

P06.12 - Longitudinal Proteomic Profiling of Dialysis Patients with COVID-19 Reveals Markers of Severity and Predictors of Death (View Slides)

Jack Gisby

P06.13 - Large-Scale Discovery and Exploration of Virus-Host Interaction Motifs (View Slides)

Eszter Kassa

P06.14 - Antibody Landscape against SARS-CoV-2 Proteome Revealed Significant Differences between Non-structural/ Accessory Proteins and Structural Proteins. (View Slides)

Dan Yun Lai

P06.15 - Multi-omics Characterization of COVID-19 Reveals Risk Factors for One-year Sequelae (View Slides)

Xiao Liang

P06.19 - Systematically Exploit the IgG Responses to SARS-CoV-2 at Amino Acid Level by AbMap (View Slides)

Huan Qi

P06.20 - A COVID-19 Knowledge Graph for Therapeutic Discovery from Semantic Integration of Literature and Databases (View Slides)

Karen Ross

P06.22 - Systematical Deciphering of SARS-CoV-2 Specific Humoral Immune Responses (View Slides)

Sheng-ce Tao

P07.01 - Saliva Protein Signatures of Smokers Enrolled in Lung Cancer Screening for Early Diagnosis and Clinical Management. (View Slides)

Stefania Angelucci

P07.02 - Connecting Molecular Pathology and Precision Oncology: Development and Validation of a Quantitative Immuno-MRB Assay for The PD-1/PD-L1 Axis (View Slides)

Vincent Lacasse

P07.03 - Extracellular Vesicle Protein Biomarkers of Cardiac AL Amyloidosis (View Slides)

Sandrine Bourgoin

P07.05 - Phospho-Proteome Analysis of Cerebrospinal Fluid Extracellular Vesicles in Primary Central Nervous System Lymphoma (View Slides)

Yuanyuan Deng

P07.06 - Mapping Isoform Abundance and Interactome of the Endogenous TMPRSS2-ERG Fusion Protein in Prostate Cancer (View Slides)

Andrei Drabovich

P07.08 - Proteomic Profiling of Ankylosing Spondylitis Patients Serum Reveals Biomarkers for Therapeutic Response Prediction and Associated Mechanistic Insights (View Slides)

Ana Fernandes

P07.11 - Cancer-Testis Antigen and Immune Profiling in Non-Small Cell Lung Cancer by Transcriptomics and Antibody-Based Proteomics (View Slides)

Feria Hikmet Noraddin

P07.12 - Cytokines and Chemokines Analysis of Malignant Pleural Effusions (View Slides)

Xiaomin Hu

P07.13 - Comprehensive Serum Proteome Analysis for Signatures Development in High-Grade Serous Ovarian Cancer (View Slides)

Un-Beom Kang

P07.14 - Diagnostic Value of Multiple Serum Protein Marker in Breast Cancer Based on Proteomics Technique (View Slides)

Yumi Kim

P07.15 - The Effect of Storage Time and Temperature on MS Analysis of FFPE Tissue Sections (View Slides)

Jennifer Koh

P07.16 - Identification of Key Protein Markers of Colorectal Cancer for the Development of the Disease by TMT-Quantitative Proteomics (View Slides)

Ana Montero Calle

P07.17 - Automated Proteomics Sample Preparation of Extracellular Vesicles from Human Plasma and Serum (View Slides)

Satoshi Muraoka

P07.19 - Proteomic Profiles of Zika Virus-Infected Placentas Bearing Foetuses with Microcephaly (View Slides)

Mauricio Quiñones-Vega

P07.20 - Discovery of Prostate Cancer Biomarkers by Immunoaffinity Proteomics. (View Slides)

Yasmine Rais

P07.21 - A Multi-Omics LC-MS Approach for Rational Selection of Neo-Antigens and Unbiased Detection of Corresponding Neo-Epitopes from Low Number of Cells (View Slides)

P07.22 - Label-free Proteomics Profile from Spleens of Lupus-like cGVHD WT Mice Reflects a STAT-1-driven Type I IFN-signature (View Slides)

Jaime Sancho

P07.23 - Cardiac Sex Disparities are Established Prior to Gonad Formation (View Slides)

Xinlei Sheng

P07.24 - Serological Profiling of Crohn's Disease and Ulcerative Colitis Sera Reveal Microbial Antibody Markers (View Slides)

Mahasish Shome

P07.25 - Quantitative Proteome Profiling ties the Complement System to Amyloidosis (View Slides)

Christian Treitz

P07.26 - Clinical Mass Spectrometry Center Munich (CLINSPECT-M): Adding a Proteomic Component to Molecular Tumor Boards (View Slides)

P07.27 - Peptide and Metabolite Profiling in Histological Variants of Papillary Thyroid Carcinoma (View Slides)

Yasemin Ucal

P07.28 - Serum Proteomic Analysis of Severe Eosinophilic Asthma Patients before and after Two New Biological Therapies (View Slides)

Lorenza Vantaggiato

P07.29 - Mass Spectrometry-Based Proteomic and Metabolomic Profiling of Serum Samples for Discovery and Validation of TB Diagnostic Biomarker (View Slides)

Ana Varela Coelho

P07.30 - Cell Type Deconvolution of Brain Proteomes (BrainDecon) (View Slides)

Theodore Verhey

P08.01 - Development of a Targeted Proteomics Method for Serum IGF-I, IGF-II, IGFALS and IGFBP-1, 2, 3, 4, 5 and 6. (View Slides)

Jakob Albrethsen

P08.03 - Bench-to-Bedside Alzheimer Disease's Detection by Biosensing Approaches Detecting Autoantibody Biomarkers Identified by Protein Microarrays-Based Proteomics (View Slides)

Rodrigo Barderas

P08.04 - Precision Analysis Reveals Diagnostic Protein Biomarkers of Japanese Encephalitis Virus Infection in Cerebrospinal Fluid (View Slides)

Tehmina Bharucha

P08.05 - Application of 16O/18O Labeling in Characterization of Thyroid Cancer Patient (View Slides)

Ing-Feng Chang

P08.06 - Tumor Outflow Pulmonary Blood Derived Exosome GCC2 act as a Clinically Informative Biomarker in Patients with Surgically Resected Lung Adenocarcinoma (View Slides)

Byeong Hyeon Choi

P08.07 - Multi-Staged Enrichment Method Capable of Quantifying Mutant Frameshift MUC1 in Urine from Patients with Autosomal Dominant Tubulointerstitial Kidney Disease (ADTKD-MUC1) (View Slides)

Kristen Doucette

P08.08 - Identification of Procalcitonin in Septic Patients Serum by Affinity Chips and Mass Spectrometry (View Slides)

Josef Dvořák

P08.09 - Proteomic Analysis of Synovial Liquid to Search for Severity Biomarkers in Osteoarthritis (View Slides)

Patricia Fernandez Puente

P08.10 - An Intelligent Hybrid-Dia Data Acquisition Strategy for Cracking the Clinical Sample Complexity Challenge in Translational Proteotyping (View Slides)

P08.11 - Cyclic Ion Mobility-Enabled Mass Spectrometer and Application to High Throughput Plasma Proteomics (View Slides)

Chris Hughes

P08.12 - Species-Specific Cutaneous Protein Signatures of Incision Injury and Correlation with Distinct Pain-Related Phenotypes in Humans (View Slides)

Christin Kappert

P08.13 - Proteomic Signature Associated with Prognosis in HPV-Related Oropharyngeal Squamous Cell Carcinoma (View Slides)

Jia (Jenny) Liu

P08.14 - Identification of Protein Biomarkers in FFPE Primary Tissues to Predict Recurrence in Endometrial Cancer (View Slides)

Carlos López Gil

P08.15 - Protein Biomarkers in Pipelle Biopsies to Diagnose the Histological Type and Grade of Endometrial Cancer and Predict Tumor Recurrence (View Slides)

Elena Martinez Garcia

P08.16 - Immunopeptidomics-Based Development of a Listeria mRNA Vaccine (View Slides)

Rupert Mayer

P08.17 - Regulation of Protein Cargo in Extracellular Vesicles during Cancer Onset (View Slides)

Orlando Morales-tarré

P08.19 - Evaluation of Melanoma Plasma Proteome Profile and the Modulation of Plasma Proteins Based on Tumor Proliferation (View Slides)

Natália Pinto de Almeida

P08.20 - Diagnosis of Pleural Effusions Using Mass Spectrometry-Based Targeted Proteomics (View Slides)

Aleksandra Robak

P08.21 - An 8-Channel Automatic Glycan Profiling System Realized by The GlycoBIST Technology (View Slides)

Hiroko Shimazaki

P08.22 - Proteogenomics for splicing variation and differential expression: a myotonic dystrophy type 1 mouse model study (View Slides)

Elizaveta Solovyeva

P08.24 - Discovery of Soluble Pancreatic Cancer Biomarkers Using Innovative Clinical Proteomics and Statistical Learning. (View Slides)

Guillaume Tosato

P08.25 - Discovery of Candidate Stool Biomarker Proteins for Biliary Atresia Using Deep Proteome Analysis by Data-Independent Acquisition Mass Spectrometry (View Slides)

Eiichiro Watanabe

P08.26 - Large scale, deep and unbiased plasma proteomics profiling a sub-study of a multi-cancer cohort enabling biomarker discovery (View Slides)

Bruce Wilcox

P08.27 - Unbiased High-Throughput Mass Spectrometry-Based Plasma Proteomics for Detection of Early Stage Lung Cancer (View Slides)

Matthew Willetts

P08.28 - Proteomic Characterization of Primary Tumors and Brain Metastases in Lung Adenocarcinoma Patients (View Slides)

Nicole Woldmar

P08.29 - A Pan-Cancer Proteomic Map of 960 Human Cell Lines (View Slides)

Qing Zhong

P08.30 - A Fully Automated High-Throughput, Deep-Scale Quantitative Plasma Proteomics Workflow Enables Quantitively Profile More Than 1000 Proteins Per Sample (View Slides)

Yu Zhou

P08.31 - Accurate Quantitation of Clinically Approved Cancer Biomarkers Utilising SRM (View Slides)

Erin Sykes

P09.01 - Proteomics of the Acquired Resistance to Targeted Kinase Inhibition in Pancreatic Cancer Cells (View Slides)

Alain Aguilar-Valdes

P09.02 - Proteomic Characterization of two Extracellular Vesicle Subtypes Isolated from Human Glioblastoma Stem Cell Secretome by Sequential Centrifugal Ultrafiltration (View Slides)

Stefania Angelucci

P09.04 - DIA-MS Identifies and Validates Transgelin as Protein Contributing to a Poor Response of Metastatic Renal Cell Carcinoma to Sunitinib Treatment (View Slides)

Pavla Bouchalova

P09.06 - Efficient Profiling of Protein Degraders by Specific Functional and Target Engagement Readouts (View Slides)

Alexey Chernobrovkin

P09.07 - Label Free Pharmacoproteomic Assays Enabled the Discovery of Cellular Pathways Involved in the Survival Of MCF-7 and K562 Cancer Cells (View Slides)

Cristina Clement

P09.09 - Proteomic Analysis of Equine Serum Antibody Repertoire against Loxosceles Venom. (View Slides)

Manuela Cristina Emiliano Ferreira

P09.10 - Discovering Substrates of PRMT5 and CDK4/6 In Human Melanoma Cells with Antibody-Based PTM Peptide Specific Enrichment Strategies. (View Slides)

Charles Farnsworth

P09.11 - Improved Middle-down Characterization of Antibodies Using Proton Transfer Charge Reduction on a Tribrid Orbitrap Mass Spectrometer (View Slides)

Luca Fornelli

P09.12 - Combatting Fungal Infections: Novel Anti-virulence Strategies and Reversing Antifungal Resistance. (View Slides)

Jennifer Geddes-McAlister

P09.13 - Proteomic Unraveling of the Hidden Regulators of Erythropoiesis (View Slides)

P09.14 - Effects of Salicornia-Based Cream Skin Application on a Human Experimental Model of Pain and Itch. (View Slides)

Rocco Giordano

P09.15 - Transcriptional and Translational Dynamics Underlie Synergy in Endothelial Inflammation (View Slides)

Stijn Groten

P09.16 - Comprehensive Biological Characterization of Novel Antitumor Nanoconjugates by Newly Synthesized Proteomes with Bioorthogonal Non-canonical Amino-Acid Tagging. (View Slides)

Angela-Patricia Hernandez

P09.17 - Proteomic Basis for Understanding the Combination of Gemcitabine and Kinase Inhibitors to Kill Pancreatic Cancer Cells (View Slides)

Stefanie Hoefer

P09.18 - Developing and Validating a Set of Targeted Mass Spectrometry Assays for Pan-Herpesvirus Viral Protein Detection and Monitoring of Infection Progression (View Slides)

Michelle Kennedy

P09.19 - Target Identification of a Natural Compound Regulating Mitochondria-ER Interaction Using DARTS-LC-MS/MS (View Slides)

Minjeong Ko

P09.20 - The Cell Membrane Proteome: From Cancer Hallmarks to Therapeutic Interventions (View Slides)

Iulia Lazar

P09.21 - The Chemoproteomic Target Landscape of HDAC Inhibitors Highlights MBLAC2 as Common Off-Target (View Slides)

Severin Lechner

P09.22 - Label-Free Dia-PASEF Compared to TMT Quantitation for Thermal Proteome Profiling / Cellular Thermal Shift Assay (View Slides)

Johan Lengqvist

P09.23 - Proteomics Profiling of Systemic Effects of Bovine Colostrum Diet in Preterm Piglets - A Translational Model for Neonate Disease Pathology (View Slides)

Azra Leto

P09.24 - Target Identification, Selectivity Profiling and Mechanistic Insights of a Cdk9 Inhibitor Using Complementary Proteomics Methods (View Slides)

Daniel Martinez Molina

P09.25 - Systems-based Examination of DLK-MAPK Signaling in Human Stem Cell Derived Retinal Ganglion Cells during Cell Death (View Slides)

Joseph Mertz

P09.27 - Establishment and Characterization of a Novel Cancer Stem Cell Derived from Cholangiocarcinoma by Proteomics (View Slides)

Orasa Panawan

P09.28 - Dynamic Polygon for MHC Class I and II Immunopeptides (View Slides)

P09.29 - Metalloproteomic Analysis of Brazilian Snake Venoms as Proof of Concept for the Development of a Diagnostic Kit for Snakebites (View Slides)

Lucilene Delazari Dos Santos

P09.30 - Quantitative Proteomics Shows High Selectivity and Reveals the Mechanism-of-Action of a STAT3 Degrader (View Slides)

Yatao Shi

P09.31 - Kitted universal MAM: automatable sample processing for all stages of biological drugs (View Slides)

John Laycock

P09.32 - Integrated Proteomics Revealed Acetylation-Induced PCK Isoenzyme Transition Promotes Metabolic Adaptation of Liver Cancer to Systemic Therapy (View Slides)

Xiaohang Zhao

P10.01 - Global Proteome Expression Study of Patient-Derived Sarcoma Cell-Lines toward Optimization of Therapeutic Strategy Using Relocated Anti-cancer Drug (View Slides)

Taro Akiyama

P10.02 - Kitted universal MAM: automatable sample processing for all stages of biological drugs (View Slides)

John Laycock

P10.04 - Cell Surface Phenotyping of the Human Heart Reveals Cardiomyocyte-Specific Targets and Surfaceome Dynamics of Explanted Cardiac Fibroblasts (View Slides)

Linda Berg Luecke

P10.05 - The Secretome Deregulations in a Rat Model of Endotoxemic Shock (View Slides)

Sandrine Bourgoin

P10.06 - Two Novel Serum Biomarkers Are Associated with the Serological Status of Rheumatoid Arthritis Patients: A Tool for Precision Medicine Strategies (View Slides)

Valentina Calamia

P10.08 - Development of a Standardized MRM Targeted Proteomics Method for Monitoring One-Carbon Metabolism Enzymes in Hepatocellular Carcinoma and Cirrhosis (View Slides)

Fernando Corrales

P10.09 - The Proteomic Analysis of High Grade Serous Ovarian Cancer Reveals the Role of Tumor Microenvironment in Chemoresistance. (View Slides)

Kruttika Dabke

P10.10 - A Quantitative Discovery Platform to Survey the Human Blood Plasma Proteome in Precision Oncology (View Slides)

P10.12 - Functional Protein Discovery for the Early Diagnosis of Neonatal Sepsis (View Slides)

Julie Hibbert

P10.13 - Fast Library Generation Using Zeno MS/MS and Microflow Chromatography (View Slides)

P10.14 - Precise Quantitation of PTEN by Immuno-MRM: A Tool to Resolve the Breast Cancer Biomarker Controversy (View Slides)

Sahar Ibrahim

P10.16 - Development of a Parallel Reaction Monitoring Assay for the Quantification of Interferon Alpha Subtypes (View Slides)

Martha Ingola

P10.17 - Cancer SHooting ARrow Proteomics (cSHARP) to Target OnCo-proteogenomic Panels in a Quadrupolar Environment (View Slides)

Yasushi Ishihama

P10.18 - Biomarker Monitoring in Body Fluid by High Sensitivity and High Throughput FAIMS-Surequant™ Is Targeted Quantitation (View Slides)

Konstantinos Kalogeropoulos

P10.19 - Optimization of the protocol for collection and proteomic analysis of exhaled breath condensate for the lung cancer diagnostics (View Slides)

Anna Kozyr

P10.20 - A Multi-Faceted System for Differential Glycoprotein Analysis: Toward the “Design Drawings” of GlyCo-targets for the Highly Specific Antibody Drug Development (View Slides)

Atsushi Kuno

P10.21 - Kinome Analysis of CIC-Rearranged Sarcoma Using Peptide Microarray; Global Investigation of Kinases Affected by Culture Condition (View Slides)

Yu Kuwata

P10.22 - Evaluation of Humoral Immune Dysfunction in Chronic Lymphocytic Leukemia by Affinity Proteomics. (View Slides)

Alicia Landeira Viñuela

P10.23 - A Large-Scale Assay Library for Targeted Protein Quantification in Renal Cell Carcinoma Tissues (View Slides)

Petr Lapcik

P10.24 - Discovery and Validation of Circulating Autoantibodies Associated with the ACPA Status in Early Rheumatoid Arthritis (View Slides)

Lucia Lourido

P10.25 - Integrated Proteomic and Glycoproteomic Signatures of Protein N-Glycosylation Aberrations in Ulcerative Colitis (View Slides)

Cheng Ma

P10.27 - Global Immunopeptidomics by Differential Ion Mobility Mass Spectrometry for Identification of Patient Specific HLA-Presented Antigens Directly from Clinical Tissues (View Slides)

Yuriko Minegishi

P10.29 - Immunoproteomics Characterization of Ligustrum Lucidum Pollen Allergens Causing Respiratory Allergies in Polysensitized Patients (View Slides)

Josaphat Miguel Montero-Vargas

P10.30 - Autoantigenomics in Neurology: Holistic Characterization of Autoantigen Repertoires Identifies Patient Subgroups and a Novel Target of Autoantibodies in CIDP (View Slides)

Christian Moritz

P10.31 - The Urine Proteome/Degradome Using N-Terminomics with TMPP-Labelling on the Proteome and Peptidome Fractions (View Slides)

Leslie MULLER

P10.32 - A Multi-Faceted System for Differential Glycoprotein Analysis: Toward the Discovery of Disease-Related Glycosylation Alterations Using Tissue Crude Samples (View Slides)

Chiaki Nagai-Okatani

P10.33 - Personalised Phosphoproteomics Identifies Functional Signalling (View Slides)

Elise Needham

P10.34 - Mass Spectrometry-Based Proteomics of Multiple Sites Reveals Signature of Lymph Node Metastasis for Head and Neck Cancer (View Slides)

Adriana Paes Leme

P10.35 - MASTER INFORM Pro - Proteome Profiling for Personalized Oncology (View Slides)

Julia Rechenberger

P10.37 - Proteomics-Informed Two Stage Model of Resistance in Acute Myeloid Leukemia: Identification of Novel Therapeutic Targets to Inhibit Early Resistance (View Slides)

Karin Rodland

P10.38 - Differential Molecular Signatures in Synovial Membrane and Synovial Fluid from Patients with Rheumatoid Arthritis and Psoriatic Arthritis (View Slides)

Cristina Ruiz-Romero

P10.39 - Proteomic-Based Precision Medicine for Companion Diagnostics in Autoimmune Diseases (View Slides)

Jacob Skallerup

P10.40 - Aryl Hydrocarbon Receptor-Interacting Protein Regulates Tumorigenic and Metastatic Properties of Colorectal Cancer Cells Driving Liver Metastasis (View Slides)

Guillermo Solís-Fernández

P10.41 - Proteomic Analysis Identifies Unique Signatures in Small Cell Lung Cancer Subtypes. (View Slides)

Beáta Szeitz

P10.42 - Precision Proteomics in Allergy: Pecan Pollen Allergens (View Slides)

Luis M. Teran

P10.43 - Novel Candidate Drugs for Malignant Peripheral Nerve Sheath Tumor Revealed by Mass Spectrometry and Drug Screening Using Patient-Derived Cell Lines (View Slides)

Ryuto Tsuchiya

P10.44 - Patient-Derived Sarcoma Model; Pivotal Research Resource for Proteomics (View Slides)

Yuki Yoshimatsu

P10.45 - Urinary Proteins RAD23B and CORO1C Associated with Colorectal Cancer Progression and Metastasis (View Slides)

Xiaohang Zhao

P10.46 - Development of a Multiplexed Protein Panel Using a Targeted-Proteomics Approach for the Study of Resistance to CDK4/6-Inhibitors in Breast Cancer (View Slides)

Marta Zurawska